How quickly you will lose weight is tied to factors like the dose of semaglutide GLP-1 youre taking, how well youre following dietary recommendations, and how much physical activity you engage in
Theme 3: Off-Label Use in Type 1 Diabetes (T1D) Although GLP-1s are not approved for people with T1D, some individuals with T1D are using them off-label, particularly if they live with obesity, strong insulin resistance, or significant post-meal blood sugar spikes
While these injections have proven beneficial in managing type 2 diabetes and reducing HbA1c levels, they also contribute to cardiovascular health
Lower fluid intake and higher fluid loss reduce urine volume, and urine volume is one of the main determinants of stone risk, Wood explained
If you develop a firm raised area at a previous injection site, avoid that spot until it resolves and mention it to your prescriber at the next appointment
This personalised approach to titration is an important safety feature and underscores why retatrutide must only be used under close medical supervision within an approved research framework